Spondyloarthritis & psoriatic arthritis

Understanding the Psoriasis Phenotype Associated With Psoriatic Arthritis Using the PURE-4 Questionnaire: Insights From Spanish Real-World Settings

J RheumatolPublished Cohort study

Authors' conclusion

Greater PsO involvement in neck, knees, hands, and feet as well as in high-impact areas of patients who developed PsA provides additional information on the arthritogenic phenotype of PsO in our study population compared to locations generally linked to arthritis risk, such as the nails or scalp.

Study context

Population
Patients with psoriasis who completed the PURE-4 validation study, Spanish real-world settings
Participants
253 patients
Exposure
Patients with PsO who developed psoriatic arthritis (PsA) vs PsO only
  • PsAn = 46
Outcome
Baseline PsO location
Follow-up
Baseline
Methodological detailsanalysis of the PURE-4 validation study, real-world settings
  • Analysis of the PURE-4 validation study
  • Real-world settings

Main finding

As reported in the abstract

PsA
neck involvement 13% vs 3.4%; P < 0.01
PsA
knee involvement 71.4% vs 50%; P = 0.02
PsA
hand involvement 40% vs 17.7%; P < 0.01
PsA
feet involvement 22.9% vs 9.8%; P = 0.03

Observational data: associations, not effects.

Further findings

PURE-4 item 4 (peripheral joint pain with swelling), Assessment I

P = 0.03

PURE-4 item 4 (peripheral joint pain with swelling), Assessment II

P < 0.01

OutcomePsAPsO onlyP value
PASI · baseline8.7 (SD 5.6)6.8 (SD 5.0)P = 0.03
DLQI · baseline9.9 (SD 6.9)7.6 (SD 6.7)P = 0.09
  • PURE-4 item 4 (peripheral joint pain with swelling), Assessment I: most prevalent PURE-4 item among PsA

Original publication

Understanding the Psoriasis Phenotype Associated With Psoriatic Arthritis Using the PURE-4 Questionnaire: Insights From Spanish Real-World Settings. J Rheumatol. Published 1 June 2025. doi:10.3899/jrheum.2024-1202

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.